That's up from around $60bn now. Last year, 750,000 Americans sought treatment abroad and the number is expected to soar to 10 million by 2012 - all driven by America's famously costly healthcare system. Patients are increasingly heading for India, Thailand and Singapore, where treatment can cost as little as 10% of the equivalent in the US. Brits are giving foreign hospitals a cash injection too. Snaking waiting-lists, ravenous super-bugs and the expense of private care on these shores have had us looking elsewhere for hip replacements, boob jobs and teeth-whitening. Destination: anywhere, from France to Goa. Even Israel is now marketing itself as a hub for medical tourism. India was the top destination for Brits last year, claiming a total of 175,000 health tourists. The sums certainly seem sound: at £850, a nose job there will cost about a quarter of the price of having it done in the UK. Critics may point to the risks - such as uncertainties over hygiene, training and legal issues if it all goes wrong - but, clearly, our own health system is no longer immune. Nye Bevan would not approve.
Faisal Butt seeks some perspective in contemplation, patience and fasting.
Brexit is an opportunity for regulators to enable innovation while protecting wider society, says PA Consulting's Conrad Thompson.
The generations have much to learn from each other, says veteran hospitality entrepreneur turned Airbnb advisor Chip Conley.
The best ideas rarely come from behind a door marked 'Innovation Department'.
The search for new products, new routes to market and new business models can't stop at your front gate, says AAR's Robin Charney.
The tech boss has already done the hard work of letting go, says Simon Hayward.